Skip to main content

Coronavirus: Probiotics

Question for Department of Health and Social Care

UIN 111573, tabled on 25 January 2022

To ask the Secretary of State for Health and Social Care, with reference to a recent research paper entitled Probiotic improves symptomatic and viral clearance in covid-19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial, what assessment he has made of the implications for his policies of the findings of that research that probiotics improve symptomatic and viral clearance in covid-19 outpatients.

This answer is the replacement for a previous holding answer.

Answered on

31 January 2022

No formal assessment has been made. However, the Therapeutics Taskforce is monitoring data from clinical trials taking place worldwide to identify safe and effective treatments for COVID-19. The Taskforce works closely with RAPID C-19, a multi-agency group from across the health system, to review and evaluate evidence on the effectiveness of promising COVID-19 treatments when clinical trial data becomes available.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.